AUSTIN, Texas, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.?(NASDAQ:MTEM, "Molecular Templates, " or "MTEM")), a clinical-stage biopharmaceutical company developing novel therapeutics with potent and differentiated mechanisms of action for cancer, announced participation in the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference.
Oppenheimer 34rd Annual Healthcare Conference, February 13 – 14
- Format: Virtual Presentation
- Date: Wednesday, February 14, 2024
- Time: 9:20 – 9:50am Eastern Time
- Webcast access: The live-streamed webcast can be accessed here
Presentation links can be found in the "News and Media" section of the corporate website.
One-on-one meetings may be scheduled directly with Molecular Templates.
About Molecular Templates
Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics. Our proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer.
Forward-Looking Statements